De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease.
Alvaro SánchezJose Ignacio PijoanRita Sainz de RozasItxasne LekueRicardo San VicenteJose Antonio QuindimilRafael RotaecheArritxu EtxeberriaCarmela MozoMonica Martinez-CengotitabengoaMonica MongeCristina Gómez-RamírezRicardo SamperMikel Ogueta LanaSara CelorrioNerea Merino-IndaMarta LlarenaMarta Gonzalez Saenz de TejadaArturo García-AlvarezGonzalo GrandesPublished in: BMJ open (2024)
NCT04022850.
Keyphrases
- phase ii
- clinical trial
- open label
- cardiovascular disease
- primary care
- quality improvement
- placebo controlled
- phase iii
- double blind
- healthcare
- study protocol
- randomized controlled trial
- systematic review
- coronary artery disease
- cardiovascular events
- type diabetes
- cardiovascular risk factors
- emergency department
- metabolic syndrome
- adverse drug